BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 33465114)

  • 1. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin.
    Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA
    PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
    Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L
    Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
    Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S
    J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
    Ohrling K; Edler D; Hallström M; Ragnhammar P
    Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
    Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
    BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy.
    Hoffmann D; Grunwald T; Kuate S; Wildner O
    Cancer Biol Ther; 2007 Apr; 6(4):510-8. PubMed ID: 17374986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Two Subgroups of FOLFOX Resistance Patterns and Prediction of FOLFOX Response in Colorectal Cancer Patients.
    Tian S; Wang F; Lu S; Chen G
    Cancer Invest; 2021 Jan; 39(1):62-72. PubMed ID: 33258714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Graeber S; Sperling J; Kollmar O; Schilling MK
    World J Gastroenterol; 2011 Jul; 17(26):3109-16. PubMed ID: 21912453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency.
    Din FV; Stark LA; Dunlop MG
    Br J Cancer; 2005 Mar; 92(6):1137-43. PubMed ID: 15770215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.
    Cao W; Zhang X; Li R; Li Z; Lu A; Yu F; Sun L; Wang J; Wang Z; He H
    J Control Release; 2024 Apr; 368():52-65. PubMed ID: 38368946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2.
    Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M
    Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics.
    Strauss LG; Hoffend J; Koczan D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1226-34. PubMed ID: 19280186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer.
    Chang CW; Lee HC; Li LH; Chiang Chiau JS; Wang TE; Chuang WH; Chen MJ; Wang HY; Shih SC; Liu CY; Tsai TH; Chen YJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms.
    Lu W; Fu D; Kong X; Huang Z; Hwang M; Zhu Y; Chen L; Jiang K; Li X; Wu Y; Li J; Yuan Y; Ding K
    Cancer Med; 2020 Feb; 9(4):1419-1429. PubMed ID: 31893575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea.
    Lindner AU; Resler AJ; Carberry S; Oficjalska K; Bacon O; Lee CS; Choudhry A; Burke JP; Sheahan K; Cremona M; Hennessy BT; McNamara D; Doherty G; Ryan EJ; Prehn JHM
    J Mol Med (Berl); 2020 Jan; 98(1):149-159. PubMed ID: 31848663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability testing and its role in the management of colorectal cancer.
    Kawakami H; Zaanan A; Sinicrope FA
    Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.